Could a popular Weight-Loss drug be a new hope for teens with PCOS?
NCT ID NCT07169136
Summary
This study is testing if adding a GLP-1 agonist medication (a type of drug used for weight loss) to standard diet and exercise advice can help regulate reproductive hormones in teenage girls who have both obesity and Polycystic Ovary Syndrome (PCOS). Researchers will enroll up to 20 girls aged 12-18 and treat them for 16 weeks to see if the medication improves their hormone patterns, body composition, and insulin sensitivity.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY (DISORDER) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Nemours Children's Clinic
RECRUITINGJacksonville, Florida, 32207, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.